January 26, 2015 1:49 PM ET


Company Overview of Psychiatric Genomics, Inc.

Company Overview

Psychiatric Genomics, Inc., a genomics-based drug discovery company, develops and creates small molecule drugs for the treatment of psychiatric diseases. The company is based in Rockville, Maryland.

1211 Parklawn Drive

Suite 202

Rockville, MD 20852

United States

Key Executives for Psychiatric Genomics, Inc.

Chief Executive Officer and Director
Founder and Director
Age: 68
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
SphingoGene, Inc. United States
Jenken Biosciences, Inc. United States
Cannex Therapeutics LLC United States
Targa Therapeutics Corporation United States
K-V Discovery Solutions, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Psychiatric Genomics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.